Meghmani Organics merger vote: NCLT meetings June 2026

What happened on June 6, 2026

Meghmani Organics Limited held a National Company Law Tribunal (NCLT)-convened meeting of its unsecured creditors on June 06, 2026. The meeting was called to consider a Scheme of Amalgamation involving Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited merging into Meghmani Organics as the transferee company. The company said the voting results will be disseminated later.

The June 6 meetings form part of a broader NCLT-directed process for shareholder and creditor approvals across all three companies involved in the scheme. The amalgamation has an appointed date of January 1, 2026, and it will require approval from the requisite majorities of shareholders and creditors before NCLT sanction.

Scheme of amalgamation: entities and objectives

Under the proposed scheme, Kilburn Chemicals Limited (Transferor Company 1) and Meghmani Crop Nutrition Limited (Transferor Company 2) will be amalgamated with Meghmani Organics Limited. Both transferor companies are described as wholly-owned subsidiaries in the disclosures.

Meghmani Organics has stated that the scheme is intended to simplify the group structure and bring operational synergies. The stated rationale includes structural simplification, consolidation of subsidiary operations, and improved efficiency through better resource allocation.

NCLT orders that set the process in motion

The NCLT Ahmedabad Bench issued directions on April 20, 2026, on an application filed under Sections 230–232 of the Companies Act, 2013, seeking approval of the scheme of amalgamation. The directions were subsequently amended by an order dated April 30, 2026.

As part of these directions, the Tribunal addressed whether meetings should be held or dispensed with, based on consent affidavits and outstanding liabilities. The Tribunal recorded that all equity shareholders and the sole preference shareholder of Meghmani Crop Nutrition, both controlled by Meghmani Organics, consented to the scheme, and it dispensed with their meetings. However, due to outstanding liabilities, the Tribunal directed the convening of meetings of secured and unsecured creditors in the transferor companies.

The Tribunal also directed meetings for Meghmani Organics to be convened for its equity shareholders and creditors. For Meghmani Organics, the Tribunal directed the convening of meetings of 1,37,915 equity shareholders, six secured creditors, and 1,002 unsecured creditors.

Meeting schedule across Meghmani Organics and subsidiaries

All NCLT-directed meetings were scheduled for June 06, 2026, and were to be conducted through Video Conferencing or Other Audio-Visual Means (VC/OAVM), in line with the Companies Act, 2013, relevant MCA circulars, and SEBI circulars.

E-voting window and key participation details

For the NCLT-directed equity shareholders meeting of Meghmani Organics, the company disclosed a detailed timetable and participation framework. The meeting was scheduled for Saturday, June 06, 2026 at 2:00 p.m. IST through VC/OAVM.

The cut-off date for notice eligibility was Friday, March 27, 2026. The cut-off date for e-voting eligibility was Saturday, May 30, 2026. Remote e-voting was scheduled to open on Wednesday, June 3, 2026 at 9:00 a.m. IST and close on Friday, June 5, 2026 at 5:00 p.m. IST. The Electronic Voting Sequence Number (EVSN) disclosed for the equity shareholders meeting was 260227. Separately, the disclosures also referenced an EVSN 260232 in connection with the secured creditors’ meeting.

Newspaper publication and SEBI (LODR) compliance

Meghmani Organics said it published newspaper notices in Financial Express for the proposed amalgamation scheme, following the NCLT Ahmedabad Bench orders dated April 20 and April 30, 2026. As a further compliance step under Regulation 47 of SEBI (LODR) Regulations, 2015, the company filed a newspaper publication on May 05, 2026 (Ref: MOL/2026-27/16).

The filing enclosed copies of advertisements published in Financial Express (English, All India Edition) and Financial Express (Gujarati Edition), containing the notice of the Tribunal-convened meetings.

Financial and operational snapshot disclosed with the scheme

Alongside the scheme approvals, the board disclosed summary financial metrics for the two wholly-owned subsidiaries as of 31.12.2025. Kilburn Chemicals Limited was described as a manufacturer of Anatase Grade Titanium Dioxide.

The disclosures also included creditor details for Meghmani Crop Nutrition and noted the creditor base for Meghmani Organics as part of the Tribunal’s directions.

Why the “no share issuance” point matters

Meghmani Organics disclosed that the merger is structured with no share issuance and no change in the shareholding pattern, with promoter shareholding indicated at 48.98% pre and post. This detail is typically relevant because it indicates the amalgamation is an internal consolidation of wholly-owned subsidiaries rather than a transaction changing ownership at the parent level.

The company has positioned the scheme as a move to simplify the overall group structure, optimize and pool resources, and deliver operational and financial synergies. The approvals remain subject to shareholders, creditors, the NCLT, and other regulatory authorities.

Parallel board decision: renewable power procurement plan

Separately, the board also approved a ₹3.63 crore investment in a 3.30 MW Wind Solar Hybrid power plant. Meghmani Organics said it will procure 51% power from the plant for 25 years. The disclosure links this decision to a longer-term power arrangement, alongside the group restructuring actions.

What to watch next

Meghmani Organics has said voting results from the June 06, 2026 unsecured creditors meeting will be disseminated later. The amalgamation will still require completion of the broader approval process and NCLT sanction, consistent with the scheme process under Sections 230–232.

The next formal update for investors is expected to be the publication of voting outcomes and the subsequent steps in the NCLT process for the scheme’s final approval.